Apply for RFA AT 17 003
- The Department of Health and Human Services, National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Research Resource for Systematic Reviews of Complementary and Integrative Health (R24)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
- This funding opportunity was created on Jun 26, 2017.
- Applicants must submit their applications by Aug 21, 2017.
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Public and State controlled institutions of higher education.
Browse more opportunities from the same category: Health
Next opportunity: Building English Teaching Capacity
Previous opportunity: INL17GR0041-INLC-06112017
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.Apply for RFA AT 17 003
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AT 17 003) also looked into and applied for these:
|Funding Number||Funding Title|
|CDC RFA PS18 1802||Integrated HIV Surveillance and Prevention Programs for Health Departments|
|RFA 674 17 000005||Ready, Resourceful, Risk Aware (Triple R): OVC, Adolescent Girls and Young Women|
|HRSA 18 001||Ryan White HIV/AIDS Program Part C HIV Early Intervention Services Program: Existing Geographic Service Areas|
|HRSA 18 005||Ryan White HIV/AIDS Program Part C HIV Early Intervention Services Program: Existing Geographic Service Areas|
|HRSA 18 004||Ryan White HIV/AIDS Program Part C HIV Early Intervention Services Program: Existing Geographic Service Areas|
|EP IDS 17 004||Enhancing Public Health Emergency Preparedness and Response Capacities in the Americas|
|RFA NS 17 024||Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)|
|DOS APSGP FY17 001||U.S. Ambassador’s PEPFAR Small Grants Program 2017-2018|
|CDC RFA DP17 1704PPHF17||PPHF-2017-Building Public Health Infrastructure in Tribal Communities to Accelerate Disease Prevention and Health Promotion in Indian Country|
|HRSA 17 121||Leadership in Public Health Social Work Education (LPHSWE)|
|CDC RFA PS14 14020401SUPP17||STD AAPPS Supplemental Funding for Enhanced Congenital Syphilis Response|
|HRSA 18 061||State Systems Development Initiative Grant Program – Tier 1 (Jurisdictions)|
|HRSA 18 062||State Systems Development Initiative Grant Program – Tier 2 (States and DC)|
|HRSA 18 021||Service Area Competition|
|HRSA 18 023||Service Area Competition|
|RFA HL 18 021||Consortium Linking Oncology with Thrombosis (CLOT) (U01)|
|RFA HL 18 019||Increasing Use of Cardiac and Pulmonary Rehabilitation in Traditional and Community Settings (R61/R33)|
|CDC RFA GH17 1780||Protecting and Improving Public Health Globally: Cooperative Agreement between Ministry of Agriculture of Georgia and US Centers for Disease Control and Prevention|
|NAP AX 17 003||Certified Health IT Surveillance Capacity and Infrastructure Improvement Cooperative Agreement Program|
|RFA HL 18 018||Preparing for Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01)|
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!Apply for Grants
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 17 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.